All Stories

  1. A Novel Nanoformulation of Ellagic Acid is Promising in Restoring Oxidative Homeostasis in Rat Brains with Alzheimer’s Disease
  2. Esterification of 2-(4-(4-Hydroxy-3, 5-Iiodophenoxy)-3, 5-Diiodophenyl) Acetic Acid (Tetrac)
  3. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release
  4. IR-enhanced photothermal therapeutic effect of graphene magnetite nanocomposite on human liver cancer HepG2 cell model
  5. Date Palm (Phoenix dactylifera): Novel Findings and Future Directions for Food and Drug Discovery
  6. Action of Reverse T3 on Cancer Cells
  7. Effects of Phoenix dactylifera Ajwa on Infection, Hospitalization, and Survival Among Pediatric Cancer Patients in a University Hospital: A Nonrandomized Controlled Trial
  8. DTX loaded FA/PLGA NPs activiely targets human breast cancer
  9. Thymoquinone Attenuates Cardiomyopathy in Streptozotocin-Treated Diabetic Rats
  10. Protective Effects of Miswak (Salvadora persica) against Experimentally Induced Gastric Ulcers in Rats
  11. Chitosan-based nanoformulated (–)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis
  12. Tinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer: A Systematic Review and Meta-Analysis
  13. Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac
  14. Nanoparticle cisplatin chemotherapy targeting urinary bladder tumors and their vascularization
  15. Lipid Nanoparticles and their Application in Nanomedicine
  16. Advances in Anticogulants
  17. Advances in Antiplatelets
  18. Modulation of Sickle Red Blood Cell Adhesion and its Associated Changes in Biomarkers by Sulfated Nonanticoagulant Heparin Derivative
  19. Nanoencapsulation of pomegranate bioactive compounds for breast cancer chemoprevention
  20. Advances in Anticoagulants
  21. Advances in Antiplatelets
  22. Stem cells in the management of heart failure: what have we learned from clinical trials?
  23. Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis
  24. Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration
  25. Angiogenesis Modulations in Health and Disease
  26. Current primary open-angle glaucoma treatments and future directions
  27. Biosensors: the new wave in cancer diagnosis
  28. Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management
  29. Prevention strategies for antimicrobial resistance: a systematic review of the literature
  30. Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy
  31. Anticoagulants, Antiplatelets, and Thrombolytics
  32. Pharmacogenomics in cardiovascular disorders: Steps in approaching personalized medicine in cardiovascular medicine
  33. The implications of pharmacogenomics in the treatment of HIV-1-infected patients of African descent
  34. Pharmacogenomics in osteoporosis: Steps toward personalized medicine
  35. Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
  36. Novel Anticoagulant Therapy: Principle and Practice
  37. Safety Pharmacology of Blood Constituents
  38. Antithrombotics in Tumor Growth and Metastasis
  39. Angiogenesis Inhibitors: Current & Future Directions
  40. Anticoagulants, Antiplatelets, and Thrombolytics
  41. αυVitronectin Receptors in Vascular-Mediated Disorders
  42. New antiplatelet drugs
  43. New antiplatelet drugs
  44. Highlights of Latest Advances in Antithrombotics
  45. Tissue Factor/VIIa in Thrombosis and Cancer
  46. Arixtra® (Fondaparinux Sodium)
  47. Oral Thrombin Inhibitor Ximelagatran
  48. Are Low Molecular Weight Heparins the Same?
  49. Anti-integrins